학술논문

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial
Document Type
Article
Author
Agweng, EAwio, PBakeinyaga, GIsabirye, CKabuga, UKasuswa, SKaturamu, MKiweewa, FKyomugisha, HLutalo, EMulima, DMusana, HMusitwa, GMusiime, VNdigendawan, MNamata, HNkalubo, JLabejja, P OcittiOkello, POlal, PPimundu, GSegonga, PSsali, FTamale, ZTumukunde, DNamala, WByaruhanga, RKayiwa, JTukamushaba, JAbunyang, SEram, DDenis, OLwalanda, RMugarura, LNamusanje, JNankya, INdashimye, ENabulime, ESenfuma, OBihabwa, GBuluma, EElbireer, AKamya, DKatwere, MKiggundu, RKomujuni, CLaker, ELubwama, EMambule, IMatovu, JNakajubi, ANakku, JNalumenya, RNamuyimbwa, LSemitala, FWandera, BWanyama, JMugerwa, HNinsiima, ESsenkindu, TMwebe, SAtwine, LWilliam, HKatemba, CAcaku, MSsebutinde, PKitizo, HKukundakwe, JNaluguza, MSsegawa, KNamayanjaNsibuka, FTuhirirwe, PFortunate, MAcen, JAchidri, JAmone, AChamai, MDitai, JKemigisa, MKiconco, MMatama, CMbanza, DNambaziira, FOdoi, M OworRweyora, ATumwebaze, GKalanzi, HKatabaazi, JKiyingi, AMbidde, MMugenyi, MOkong, PSenoga, IAbwola, MBaliruno, DBwomezi, JKasede, AMudoola, MNamisi, RSsennono, FTuhirwe, SAmone, GAbach, JAciro, IArach, BKidega, POmongin, JOcung, EOdong, WPhilliam, AAlima, HAhimbisibwe, BAtuhaire, EAtukunda, FBekusike, GBulegyeya, AKahatano, DKamukama, SKyoshabire, JNassali, AMbonye, ANaturinda, T MNdukukireNshabohurira, ANtawiha, HRogers, ATibyasa, MKiirya, SAtwongyeire, DNankya, ADraleku, CNakiboneka, DOdoch, DLakidi, LRuganda, RAbiriga, RMulindwa, MBalmoi, FKafuma, SMoriku, EReid, AChidziva, EMusoro, GWarambwa, CTinago, GMutsai, SPhiri, MMudzingwa, SBafana, TMasore, VMoyo, CNhema, RChitongo, SHeyderman, RobertKabanga, LuckyKaunda, SymonKudzala, AubreyLifa, LinlyMallewa, JaneMoore, MikeMtali, ChrissieMusowa, GeorgeMwimaniwa, GraceSikwese, RosemaryZiwoya, MiltonChitete, H Chimbaka BKamanga, SMakwakwa, T Kayinga EMbiya, RMlenga, MMphande, TMtika, CMushani, GNdhlovu, ONgonga, MNkhana, INyirenda, RCheruiyot, PKwobah, CEkiru, W LokitalaMokaya, MMudogo, ANzioka, ATanui, MWachira, SWools-Kaloustian, KAlipalli, PChikatula, EKipaila, JKunda, ILakhi, SMalama, JMufwambi, WMulenga, LMwaba, PMwamba, ENamfukwe, MKerukadho, ENgwatu, BBirungi, JBoles, JBurke, ACastle, LGhuman, SKendall, LTebbs, SWhittle, JWilkes, HYoung, NSpyer, MKapuya, CKyomuhendo, FKyakundi, DMkandawire, NMulambo, SSenyonjo, SAngus, BArenas-Pinto, APalfreeman, APost, FIshola, DArribas, JColebunders, RFloridia, MGiuliano, MMallon, PWalsh, PDe Rosa, MRinaldi, EWeller, IGilks, CKangewende, ALuyirika, EMiiro, FOjoo, SPhiri, SWapakabulo, APeto, TMatenga, JCloherty, Gvan Wyk, JNorton, MLehrman, SLamba, PMalik, KRooney, JSnowden, WVillacian, JHakim, James GThompson, JenniferKityo, CissyHoppe, AnneKambugu, Andrewvan Oosterhout, Joep JLugemwa, AbbasSiika, AbrahamMwebaze, RaymondMweemba, AggreyAbongomera, GeorgeThomason, Margaret JEasterbrook, PhilippaMugyenyi, PeterWalker, A SarahPaton, Nicholas I
Source
In The Lancet Infectious Diseases January 2018 18(1):47-57
Subject
Primary Research
Articles
Language
ISSN
1473-3099